ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new ...

-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...

How important are diagnostic tests in clinical decision making? Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott's new HPV ...

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...

* ABBOTT LABORATORIES - LAUNCHING ALINITY M TO U.S. CUSTOMERS AND WILL BE MAKING SARS-COV-2 TEST AVAILABLE FOR USE UNDER AN EMERGENCY USE AUTHORIZATION Source text for Eikon: Further company coverage: ...

Abbott ABT has hit the headlines following the announcement of the receipt of CE Mark and commercial launch of Alinity h-series integrated system for hematology testing. Per management, the Alinity ...

As global healthcare changes, healthcare institutions are being tasked with handling a higher volume of patients, rising costs, and heightened performance pressures. Laboratories, in particular, are ...

Abbott has received US Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV ...